The companies' are seeking approval of the drug Lynparza in combination with other medications - biraterone and prednisone or prednisolone -for the treatment of a type of treatment-resistant prostate cancer in adult patients.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/pGwOAxU
Home »
Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com
» US FDA panel to review expanded use of Merck AstraZeneca's cancer drug
https://ift.tt/Y5kcrpM
No comments:
Post a Comment